Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 4
1984 1
1985 5
1986 6
1987 3
1988 2
1989 6
1990 6
1991 9
1992 7
1993 6
1994 8
1995 11
1996 11
1997 6
1998 4
1999 6
2000 4
2001 8
2002 7
2003 7
2004 10
2005 8
2006 11
2007 11
2008 13
2009 7
2010 13
2011 17
2012 18
2013 15
2014 19
2015 13
2016 14
2017 15
2018 16
2019 16
2020 17
2021 29
2022 20
2023 12

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune gastritis: Pathologist's viewpoint.
Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Coati I, et al. Among authors: farinati f. World J Gastroenterol. 2015 Nov 14;21(42):12179-89. doi: 10.3748/wjg.v21.i42.12179. World J Gastroenterol. 2015. PMID: 26576102 Free PMC article. Review.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Among authors: farinati f. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Reply.
Vitale A, Farinati F, Borzio M, Trevisani F, Cllo U. Vitale A, et al. Among authors: farinati f. Hepatology. 2019 Jan;69(1):465-466. doi: 10.1002/hep.30322. Hepatology. 2019. PMID: 30376183 No abstract available.
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas.
Pellino A, Brignola S, Riello E, Niero M, Murgioni S, Guido M, Nappo F, Businello G, Sbaraglia M, Bergamo F, Spolverato G, Pucciarelli S, Merigliano S, Pilati P, Cavallin F, Realdon S, Farinati F, Dei Tos AP, Zagonel V, Lonardi S, Loupakis F, Fassan M. Pellino A, et al. Among authors: farinati f. J Pers Med. 2021 Oct 26;11(11):1095. doi: 10.3390/jpm11111095. J Pers Med. 2021. PMID: 34834447 Free PMC article.
Reply.
Shalaby S, Zanetto A, Vitale A, Gambato M, Cillo U, Farinati F, Burra P, Russo FP. Shalaby S, et al. Among authors: farinati f. Liver Transpl. 2017 Dec;23(12):1630-1631. doi: 10.1002/lt.24956. Liver Transpl. 2017. PMID: 29024423 No abstract available.
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.
Stefanini B, Bucci L, Santi V, Reggidori N, Rampoldi D, Lani L, Granito A, Sangiovanni A, Cabibbo G, Farinati F, Campani C, Foschi FG, Svegliati-Baroni G, Raimondo G, Gasbarrini A, Mega A, Biasini E, Sacco R, Morisco F, Caturelli E, Vidili G, Azzaroli F, Giannini EG, Rapaccini GL, Brunetto MR, Masotto A, Nardone G, Di Marco M, Magalotti D, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Stefanini B, et al. Among authors: farinati f. Dig Liver Dis. 2022 Nov;54(11):1563-1572. doi: 10.1016/j.dld.2022.07.003. Epub 2022 Jul 27. Dig Liver Dis. 2022. PMID: 35906166
SARS-CoV-2 and hepatitis.
Trevenzoli M, Guarnaccia A, Alberici I, Fassan M, Di Meco E, Farinati F, Cattelan AM. Trevenzoli M, et al. Among authors: farinati f. J Gastrointestin Liver Dis. 2020 Sep 9;29(3):473-475. doi: 10.15403/jgld-2747. J Gastrointestin Liver Dis. 2020. PMID: 32919428 Free article. No abstract available.
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S, Donadon M, Cipriani F, Fazio F, Ardito F, Iaria M, Perri P, Conci S, Dominioni T, Lai Q, La Barba G, Patauner S, Molfino S, Germani P, Zimmitti G, Pinotti E, Zanello M, Fumagalli L, Ferrari C, Romano M, Delvecchio A, Valsecchi MG, Antonucci A, Piscaglia F, Farinati F, Kawaguchi Y, Hasegawa K, Memeo R, Zanus G, Griseri G, Chiarelli M, Jovine E, Zago M, Abu Hilal M, Tarchi P, Baiocchi GL, Frena A, Ercolani G, Rossi M, Maestri M, Ruzzenente A, Grazi GL, Dalla Valle R, Romano F, Giuliante F, Ferrero A, Aldrighetti L, Bernasconi DP, Torzilli G; HE.RC.O.LE.S. Group. Famularo S, et al. Among authors: farinati f. JAMA Surg. 2023 Feb 1;158(2):192-202. doi: 10.1001/jamasurg.2022.6697. JAMA Surg. 2023. PMID: 36576813
384 results